Literature DB >> 20352236

Balloon cells in human cortical dysplasia and tuberous sclerosis: isolation of a pathological progenitor-like cell.

Shireena A Yasin1, Kate Latak, Francesca Becherini, Anita Ganapathi, Khadijah Miller, Oliver Campos, Simon R Picker, Nelly Bier, Martin Smith, Maria Thom, Glenn Anderson, J Helen Cross, William Harkness, Brian Harding, Thomas S Jacques.   

Abstract

Neural stem cells are present in the human post-natal brain and are important in the development of brain tumours. However, their contribution to non-neoplastic human disease is less clear. We have tested the hypothesis that malformations of cortical development contain abnormal (pathological) stem cells. Such malformations are a major cause of epilepsy. Two of the most common malformations [focal cortical dysplasia (FCD) and cortical tubers] are characterised by the presence of a population of abnormal cells known as balloon cells. The identity of these cells is unknown but one hypothesis is that they are an abnormal stem cell that contributes to the pathogenesis of the malformation. We have characterised in tissue, and isolated in culture, an undifferentiated population of balloon cells from surgical resections of FCD and cortical tubers. We show that beta1-integrin labels a sub-population of balloon cells with a stem cell phenotype and show for the first time that these cells can be isolated in vitro. We have characterised the immunohistochemical, morphological and ultrastructural features of these cells. This is the first isolation of an abnormal cell with features of a progenitor/stem cell from a non-neoplastic disease of the brain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20352236     DOI: 10.1007/s00401-010-0677-y

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  15 in total

1.  Cortical dysplasia: a possible substrate for brain tumors.

Authors:  Shiyong Liu; Chunqing Zhang; Haifeng Shu; Didier Wion; Hui Yang
Journal:  Future Oncol       Date:  2012-03       Impact factor: 3.404

Review 2.  Mammalian target of rapamycin (mTOR) activation in focal cortical dysplasia and related focal cortical malformations.

Authors:  Michael Wong
Journal:  Exp Neurol       Date:  2011-10-08       Impact factor: 5.330

3.  The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission.

Authors:  Ingmar Blümcke; Maria Thom; Eleonora Aronica; Dawna D Armstrong; Harry V Vinters; Andre Palmini; Thomas S Jacques; Giuliano Avanzini; A James Barkovich; Giorgio Battaglia; Albert Becker; Carlos Cepeda; Fernando Cendes; Nadia Colombo; Peter Crino; J Helen Cross; Olivier Delalande; François Dubeau; John Duncan; Renzo Guerrini; Philippe Kahane; Gary Mathern; Imad Najm; Ciğdem Ozkara; Charles Raybaud; Alfonso Represa; Steven N Roper; Noriko Salamon; Andreas Schulze-Bonhage; Laura Tassi; Annamaria Vezzani; Roberto Spreafico
Journal:  Epilepsia       Date:  2010-11-10       Impact factor: 5.864

4.  MicroRNA-146a: a key regulator of astrocyte-mediated inflammatory response.

Authors:  Anand Iyer; Emanuele Zurolo; Avanita Prabowo; Kees Fluiter; Wim G M Spliet; Peter C van Rijen; Jan A Gorter; Eleonora Aronica
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

Review 5.  A developmental and genetic classification for malformations of cortical development: update 2012.

Authors:  A James Barkovich; Renzo Guerrini; Ruben I Kuzniecky; Graeme D Jackson; William B Dobyns
Journal:  Brain       Date:  2012-03-16       Impact factor: 13.501

6.  A quantitative study of white matter hypomyelination and oligodendroglial maturation in focal cortical dysplasia type II.

Authors:  Caterina Shepherd; Joan Liu; Joanna Goc; Lillian Martinian; Thomas S Jacques; Sanjay M Sisodiya; Maria Thom
Journal:  Epilepsia       Date:  2013-03-28       Impact factor: 5.864

Review 7.  Towards in vivo focal cortical dysplasia phenotyping using quantitative MRI.

Authors:  Sophie Adler; Sara Lorio; Thomas S Jacques; Barbora Benova; Roxana Gunny; J Helen Cross; Torsten Baldeweg; David W Carmichael
Journal:  Neuroimage Clin       Date:  2017-04-20       Impact factor: 4.881

8.  Layer-specific gene expression in epileptogenic type II focal cortical dysplasia: normal-looking neurons reveal the presence of a hidden laminar organization.

Authors:  Laura Rossini; Valentina Medici; Laura Tassi; Francesco Cardinale; Giovanni Tringali; Manuela Bramerio; Flavio Villani; Roberto Spreafico; Rita Garbelli
Journal:  Acta Neuropathol Commun       Date:  2014-04-15       Impact factor: 7.801

9.  Downregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.

Authors:  Fei-Ji Sun; Chun-Qing Zhang; Xin Chen; Yu-Jia Wei; Song Li; Shi-Yong Liu; Zhen-le Zang; Jiao-Jiang He; Wei Guo; Hui Yang
Journal:  J Neuroinflammation       Date:  2016-04-19       Impact factor: 8.322

10.  Specific pattern of maturation and differentiation in the formation of cortical tubers in tuberous sclerosis omplex (TSC): evidence from layer-specific marker expression.

Authors:  Angelika Mühlebner; Anand M Iyer; Jackelien van Scheppingen; Jasper J Anink; Floor E Jansen; Tim J Veersema; Kees P Braun; Wim G M Spliet; Wim van Hecke; Figen Söylemezoğlu; Martha Feucht; Pavel Krsek; Josef Zamecnik; Christian G Bien; Tilman Polster; Roland Coras; Ingmar Blümcke; Eleonora Aronica
Journal:  J Neurodev Disord       Date:  2016-04-01       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.